TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - COVID-19
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pandemics
KW - SARS-CoV-2
KW - United States/epidemiology
KW - Methadone
KW - opioid treatment programs
KW - telehealth
AU - L. A. Goldsamt
AU - A. Rosenblum
AU - P. Appel
AU - P. Paris
AU - N. Nazia
A1 - 
AD - Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, USA. Electronic address: lg54@nyu.edu.; NDRI-USA, 31 W. 34th St., Suite 8006, New York, NY 10001, USA. Electronic address: Abrosenblum08@gmail.com.; Stop Stigma Now, 2 Washington Square, Suite #2 A, Larchmont, NY 10538, USA. Electronic address: app924@gmail.com.; Stop Stigma Now, 2 Washington Square, Suite #2 A, Larchmont, NY 10538, USA. Electronic address: Philip.paris@ymail.com.; Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10010, USA. Electronic address: njn262@nyu.edu.
BT - Drug and alcohol dependence
C5 - Education & Workforce; Financing & Sustainability; HIT & Telehealth; Opioids & Substance Use
DO - 10.1186/s13722-021-00281-3
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PY - 2021
SN - 1879-0046; 0376-8716; 0376-8716
SP - 109049
T1 - The impact of COVID-19 on opioid treatment programs in the United States
T2 - Drug and alcohol dependence
TI - The impact of COVID-19 on opioid treatment programs in the United States
U1 - Education & Workforce; Financing & Sustainability; HIT & Telehealth; Opioids & Substance Use
U2 - 34600258
U3 - 10.1186/s13722-021-00281-3
VL - 228
VO - 1879-0046; 0376-8716; 0376-8716
Y1 - 2021
Y2 - Nov 1
ER -